These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of urinary trypsin inhibitor in experimental shock. Ohnishi H; Suzuki K; Niho T; Ito C; Yamaguchi K Jpn J Pharmacol; 1985 Oct; 39(2):137-44. PubMed ID: 2418241 [TBL] [Abstract][Full Text] [Related]
19. Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model. Zhou LW; Wang YL; Yan XT; He XH Saudi Med J; 2008 Mar; 29(3):368-73. PubMed ID: 18327361 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]